« Return to search

Bon Secours St. Francis Hospital

Survivors Served

Adult cancers (diagnosed after age 18)

Offer consultations to survivors who were not treated at the institution?

Yes

Program Name

Survivorship Clinic

Program Director

Hal Crosswell

Program Coordinator

Lori Mckitrick

Email

Website

Address

2 innovation drive
Greenville, SC 29607
USA

Appointments or new patient referrals

864 546 3699

General clinic information

864 546 3699

Serve all cancer types?

Yes

Survivors in this clinic are routinely seen by

Advanced Practice Provider (NP / PA), Pediatric Oncologist, Multidisciplinary Team, Nurse or nurse navigator, Psychologist

Which of the following eligibility criteria must survivors meet to be seen in the program?

Must have completed initial treatment (defined as surgery, chemotherapy, and/or radiotherapy)., Must be at least at X years from diagnosis, Must be disease free or have disease in remission, Neuro-oncology patients eligible, BMT patients eligible

What model of care does the program use?

Multidisciplinary : Patients seen by providers from two or more disciplines (e.g., nursing, psychology, nutrition, medical specialties, etc.), Consultative Service : One time, or additional upon request, visit to address survivorship issues, provide treatment summary, care plan and refer to subspecialties for further evaluation).

Does the institution offer special clinical programs (not just educational programs or inservices) addressing any of the following survivorship concerns?

Fatigue, Lymphedema, Fertility concerns pre and/or post treatment, Cancer or treatment related pain, Neurologic late effects (radiculopathy, plexopathy, neuropathy, myopathy, autonomic dysfunction), Psychosocial concerns / counseling, Nutritional issues, Speech and swallowing, Bladder dysfunction / Pelvic rehabilitation, Smoking cessation

More information about this clinic not captured above?

The Bon Secours St. Francis Survivorship Clinic is integrated with the Adolescent and Young Adult Oncology program and focuses on comprehensive evaluation of and recommendations for monitoring for persistent side effects and treatment related late effects of cancer therapy.